Senior insider sale
Chief Corp. & Bus. Dev. Ofcr at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$56.9K
4.06K shares
What this filing means
DOYLE JANEEN NOEL plans to sell 4.06K shares of JANUX THERAPEUTICS, INC. valued at approximately $56.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0002069239-26-000004
Officer· Chief Corp. & Bus. Dev. Ofcr
Since May 2025
4.06K
Shares to sell
$56.9K
Approx. market value
4.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation for services rendered to Issuer
6/1/2026
4.06KTotal acquired4.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Restricted Stock Units vesting under registered plan Compensation for services rendered to Issuer | 4.06K | — |
| Total | 4.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.06K
Market value
$56.9K
6/2/2026
Total
Units
4.06K
Value
$56.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/2/2026 | 4.06K | $56.9K | NASDAQ | Planned |
| Total | 4.06K | $56.9K | ||